Exploring New Digital Therapeutics Technologies for Psychiatric Disorders Using Bertopic and Patentsberta

Coronavirus disease 2019 (COVID-19) has accelerated the growth of the digital therapeutics (DTx) market; therefore, development strategies for new DTx products are necessary to satisfy market needs. However, data-driven methods for recommending digital healthcare technologies for novel DTx applications are scarce. We propose a framework that recommends potential technologies as new DTx products for specific disorders. We applied BERTopic and PatentSBERTa to patents filed with the United States Patent and Trademark Office and calculated the score of potential technologies on the basis of their thematic characteristics with respect to their digital capabilities and similarity to DTx technologies. By applying the proposed framework to psychiatric disorders—one of the largest therapeutic areas of DTx, we recommend digital monitoring technologies applicable to poor breathing or sleeping patterns for cognitive impairment. Furthermore, we provide strategies to utilize the recommended digital technologies for DTx for specific disorders to facilitate a direct intervention or treatment, which can contribute to the planning of roadmaps for DTx.